Trial Outcomes & Findings for Prevention of Early Postoperative Decline (NCT NCT02908464)

NCT ID: NCT02908464

Last Updated: 2020-06-16

Results Overview

Feasibility will be partly determined by evaluating enrollment. Enrolling \>50% of eligible patients is the target.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

45 participants

Primary outcome timeframe

Enrollment was assessed after enrollment was completed.

Results posted on

2020-06-16

Participant Flow

After participant enrollment, a baseline cognitive assessment was performed using the Montreal Cognitive Assessment (MoCA). If the patient achieved a score indicating the presence of severe baseline cognitive impairment (\<10), they were subsequently withdrawn.

Participant milestones

Participant milestones
Measure
Lumosity (CT Group)
Patients in the Lumosity arm will be prescribed a perioperative neurocognitive training program created in collaboration with Lumos Labs, Inc. The program will contain "brain games" that focus on enhancing cognitive abilities in working memory, attention, and processing speed. Participants will be expected to complete at least 2, but no more than 3, 15 minute sessions of training per day. The protocol will be prescribed for 10 days preoperatively, and then for four weeks postoperatively. Lumosity: A neurocognitive training program designed to enhance cognitive abilities
Usual Care (Control Group)
Patients in the usual care arm will undergo current standard of care for cardiac surgery and postoperative recovery. They will be asked to refrain from acquiring a Lumosity account.
Overall Study
STARTED
22
23
Overall Study
COMPLETED
20
20
Overall Study
NOT COMPLETED
2
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Lumosity (CT Group)
Patients in the Lumosity arm will be prescribed a perioperative neurocognitive training program created in collaboration with Lumos Labs, Inc. The program will contain "brain games" that focus on enhancing cognitive abilities in working memory, attention, and processing speed. Participants will be expected to complete at least 2, but no more than 3, 15 minute sessions of training per day. The protocol will be prescribed for 10 days preoperatively, and then for four weeks postoperatively. Lumosity: A neurocognitive training program designed to enhance cognitive abilities
Usual Care (Control Group)
Patients in the usual care arm will undergo current standard of care for cardiac surgery and postoperative recovery. They will be asked to refrain from acquiring a Lumosity account.
Overall Study
Withdrawal by Subject
2
1
Overall Study
Found ineligible after randomization
0
2

Baseline Characteristics

Prevention of Early Postoperative Decline

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Lumosity (CT Group)
n=20 Participants
Patients in the Lumosity arm will be prescribed a perioperative neurocognitive training program created in collaboration with Lumos Labs, Inc. The program will contain "brain games" that focus on enhancing cognitive abilities in working memory, attention, and processing speed. Participants will be expected to complete at least 2, but no more than 3, 15 minute sessions of training per day. The protocol will be prescribed for 10 days preoperatively, and then for four weeks postoperatively. Lumosity: A neurocognitive training program designed to enhance cognitive abilities
Usual Care (Control Group)
n=20 Participants
Patients in the usual care arm will undergo current standard of care for cardiac surgery and postoperative recovery. They will be asked to refrain from acquiring a Lumosity account.
Total
n=40 Participants
Total of all reporting groups
Age, Continuous
70 years
STANDARD_DEVIATION 6 • n=5 Participants
69 years
STANDARD_DEVIATION 7 • n=7 Participants
70 years
STANDARD_DEVIATION 4.5 • n=5 Participants
Sex/Gender, Customized
Male
14 Participants
n=5 Participants
15 Participants
n=7 Participants
29 Participants
n=5 Participants
Sex/Gender, Customized
Female
6 Participants
n=5 Participants
5 Participants
n=7 Participants
11 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · White
19 Participants
n=5 Participants
19 Participants
n=7 Participants
38 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Asian
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · American Indian or Alaskan Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Multi-Racial
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Unknown
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Other
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
20 participants
n=5 Participants
20 participants
n=7 Participants
40 participants
n=5 Participants
Language Status
Native born English speaker
17 Participants
n=5 Participants
19 Participants
n=7 Participants
36 Participants
n=5 Participants
Language Status
Foreign born, English is second language
3 Participants
n=5 Participants
1 Participants
n=7 Participants
4 Participants
n=5 Participants
Education Level
High school graduate or equivalent
1 Participants
n=5 Participants
5 Participants
n=7 Participants
6 Participants
n=5 Participants
Education Level
Some college, associate's degree
4 Participants
n=5 Participants
2 Participants
n=7 Participants
6 Participants
n=5 Participants
Education Level
Bachelor's degree
8 Participants
n=5 Participants
5 Participants
n=7 Participants
13 Participants
n=5 Participants
Education Level
Master's degree
5 Participants
n=5 Participants
4 Participants
n=7 Participants
9 Participants
n=5 Participants
Education Level
Doctoral degree
2 Participants
n=5 Participants
4 Participants
n=7 Participants
6 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Enrollment was assessed after enrollment was completed.

Population: This population is of patients who after screening met the eligibility criteria and were approached for this study. The total count of participants depict the total number enrolled.

Feasibility will be partly determined by evaluating enrollment. Enrolling \>50% of eligible patients is the target.

Outcome measures

Outcome measures
Measure
Overall Study Enrollment
n=69 Participants
This group includes the enrollment of patients in the Lumosity arm (CT Group), as well as the patients in the usual care arm (Control Group).
Usual Care (Control Group)
Patients in the usual care arm will undergo current standard of care for cardiac surgery and postoperative recovery. They will be asked to refrain from acquiring a Lumosity account.
Feasibility of Providing a Neurocognitive Training Program to Elderly Cardiac Surgical Patients - Enrollment
45 Participants

PRIMARY outcome

Timeframe: To be evaluated at the conclusion of the study. Adherence was assessed in 3 separate periods: pre hospital, in hospital, and post discharge (typically at the 4 week follow up clinic visit).

Feasibility will be partly determined by evaluating adherence patterns. Sufficient adherence to protocol will be deemed sufficient to deem the study feasible.

Outcome measures

Outcome measures
Measure
Overall Study Enrollment
n=20 Participants
This group includes the enrollment of patients in the Lumosity arm (CT Group), as well as the patients in the usual care arm (Control Group).
Usual Care (Control Group)
n=20 Participants
Patients in the usual care arm will undergo current standard of care for cardiac surgery and postoperative recovery. They will be asked to refrain from acquiring a Lumosity account.
Feasibility of Providing a Neurocognitive Training Program to Elderly Cardiac Surgical Patients - Adherence
Pre-Hospital Training Adherence
39 percentage of minutes trained/prescribed
Interval 20.0 to 68.0
0 percentage of minutes trained/prescribed
Interval 0.0 to 0.0
Feasibility of Providing a Neurocognitive Training Program to Elderly Cardiac Surgical Patients - Adherence
In-Hospital Training Adherence
6 percentage of minutes trained/prescribed
Interval 0.0 to 37.0
0 percentage of minutes trained/prescribed
Interval 0.0 to 0.0
Feasibility of Providing a Neurocognitive Training Program to Elderly Cardiac Surgical Patients - Adherence
Post-Discharge Training Adherence
19 percentage of minutes trained/prescribed
Interval 0.0 to 56.0
0 percentage of minutes trained/prescribed
Interval 0.0 to 0.0

SECONDARY outcome

Timeframe: Defined as present or absent on any day from postoperative day 1 to postoperative day 7.

Condition characterized by inattention and fluctuating consciousness. Measured by the Confusion Assessment Method (CAM). Inouye, S., van Dyck, C., Alessi, C., Balkin, S., Siegal, A. \& Horwitz, R. (1990). Clarifying confusion: The confusion assessment method. Annals of Internal Medicine, 113(12), 941-948.

Outcome measures

Outcome measures
Measure
Overall Study Enrollment
n=20 Participants
This group includes the enrollment of patients in the Lumosity arm (CT Group), as well as the patients in the usual care arm (Control Group).
Usual Care (Control Group)
n=20 Participants
Patients in the usual care arm will undergo current standard of care for cardiac surgery and postoperative recovery. They will be asked to refrain from acquiring a Lumosity account.
Number of Participants With Postoperative Delirium Measured by the Confusion Assessment Method (CAM)
Delrium present
5 Participants
3 Participants
Number of Participants With Postoperative Delirium Measured by the Confusion Assessment Method (CAM)
Delirium not present
15 Participants
17 Participants

SECONDARY outcome

Timeframe: Day of hospital discharge, an average of 1 week.

Population: The discrepancy of participants analyzed comes from missed assessments due to unavailability of study staff.

Condition characterized by decrease in cognitive performance by one standard deviation after surgery, as compared to baseline. Measured by the Montreal Cognitive Assessment (MoCA).

Outcome measures

Outcome measures
Measure
Overall Study Enrollment
n=17 Participants
This group includes the enrollment of patients in the Lumosity arm (CT Group), as well as the patients in the usual care arm (Control Group).
Usual Care (Control Group)
n=19 Participants
Patients in the usual care arm will undergo current standard of care for cardiac surgery and postoperative recovery. They will be asked to refrain from acquiring a Lumosity account.
Number of Participants With Postoperative Cognitive Decline
Cognitive decline present
9 Participants
7 Participants
Number of Participants With Postoperative Cognitive Decline
Cognitive decline not present
8 Participants
12 Participants

SECONDARY outcome

Timeframe: Measured at 1, 3 and 6 months postoperatively.

Population: The number analyzed decreases and increases at different time points due to the inconsistency of utilizing telephone calls to obtain cognitive scores, and the difficulty of reliably reaching patients.

Condition characterized by loss of cognitive function after surgery. Measured using the telephonic Montreal Cognitive Assessment (t-MoCA). The minimum score is 0, the maximum score is 22. The higher the score, the better the outcome.

Outcome measures

Outcome measures
Measure
Overall Study Enrollment
n=17 Participants
This group includes the enrollment of patients in the Lumosity arm (CT Group), as well as the patients in the usual care arm (Control Group).
Usual Care (Control Group)
n=19 Participants
Patients in the usual care arm will undergo current standard of care for cardiac surgery and postoperative recovery. They will be asked to refrain from acquiring a Lumosity account.
Postoperative Cognitive Dysfunction Measured Using the Montreal Cognitive Assessment (MoCA)
Postoperative t-MoCA score (0-22, 22 best) Month 1
20.0 score on a scale
Interval 18.0 to 21.0
19.0 score on a scale
Interval 18.0 to 21.0
Postoperative Cognitive Dysfunction Measured Using the Montreal Cognitive Assessment (MoCA)
Postoperative t-MoCA score (0-22, 22 best) Month 3
20.0 score on a scale
Interval 19.0 to 21.0
21.0 score on a scale
Interval 20.0 to 21.0
Postoperative Cognitive Dysfunction Measured Using the Montreal Cognitive Assessment (MoCA)
Postoperative t-MoCA score (0-22, 22 best) Month 6
20.0 score on a scale
Interval 19.0 to 22.0
20.5 score on a scale
Interval 18.0 to 21.0

OTHER_PRE_SPECIFIED outcome

Timeframe: Postoperative visit (usually within 1 month after discharge)

Population: Complete study population

Satisfaction with CT was assessed postoperatively at the follow up visit. Survey questions were both structured and open-ended. Quantitative scales were used to assess the level of agreement with prompted statements, using slide bars with visible anchors of "strongly disagree" (0), "neutral" (50), and "strongly agree" (100). The final question was only asked of the control patients to gauge their theoretical interest in using cognitive training for a future surgery.

Outcome measures

Outcome measures
Measure
Overall Study Enrollment
n=20 Participants
This group includes the enrollment of patients in the Lumosity arm (CT Group), as well as the patients in the usual care arm (Control Group).
Usual Care (Control Group)
n=20 Participants
Patients in the usual care arm will undergo current standard of care for cardiac surgery and postoperative recovery. They will be asked to refrain from acquiring a Lumosity account.
Postoperative Survey
The program was easy to use
87 Scores on a scale
Interval 75.0 to 97.0
Postoperative Survey
I enjoyed playing the games
85 Scores on a scale
Interval 79.0 to 91.0
Postoperative Survey
I think my memory improved
75 Scores on a scale
Interval 54.0 to 82.0
51 Scores on a scale
Interval 49.0 to 54.0
Postoperative Survey
I think my thinking ability improved
78 Scores on a scale
Interval 64.0 to 83.0
50 Scores on a scale
Interval 41.0 to 68.0
Postoperative Survey
I would be interested in CT for another surgery
70 Scores on a scale
Interval 50.0 to 86.0

OTHER_PRE_SPECIFIED outcome

Timeframe: Postoperative visit (usually within 1 month after discharge)

Overall satisfaction with participating in the study. Measured on a scale of 0-100 with higher values representing higher satisfaction.

Outcome measures

Outcome measures
Measure
Overall Study Enrollment
n=20 Participants
This group includes the enrollment of patients in the Lumosity arm (CT Group), as well as the patients in the usual care arm (Control Group).
Usual Care (Control Group)
n=20 Participants
Patients in the usual care arm will undergo current standard of care for cardiac surgery and postoperative recovery. They will be asked to refrain from acquiring a Lumosity account.
Patient Satisfaction
90 scores on a scale
Interval 78.0 to 94.0
74 scores on a scale
Interval 67.0 to 87.0

OTHER_PRE_SPECIFIED outcome

Timeframe: Postoperative visit (usually within 1 month after discharge)

Population: Question not asked of the CT group participants

A final question asked on the postoperative satisfaction survey: Preparation and recovery from cardiac surgery should include some form of brain training program. Results are count of participants answering yes.

Outcome measures

Outcome measures
Measure
Overall Study Enrollment
This group includes the enrollment of patients in the Lumosity arm (CT Group), as well as the patients in the usual care arm (Control Group).
Usual Care (Control Group)
n=20 Participants
Patients in the usual care arm will undergo current standard of care for cardiac surgery and postoperative recovery. They will be asked to refrain from acquiring a Lumosity account.
Postoperative Survey (Cont)
17 Participants

Adverse Events

Lumosity (CT Group)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 2 deaths

Usual Care (Control Group)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Brian O'Gara, MD, MPH

Beth Israel Deaconess Medical Center

Phone: 617-754-3189

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place